share

3-((1H-Imidazol-1-Yl)Methyl)-4,5,6,7-Tetrahydroisoxazolo[4,5-C]Pyridine CAS NO 1422069-13-3


Unit Price:

CAS No.:1422069-13-3

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3-((1H-Imidazol-1-Yl)Methyl)-4,5,6,7-Tetrahydroisoxazolo[4,5-C]Pyridine is a high-purity, advanced pharmaceutical intermediate with a complex fused heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical development companies engaged in drug discovery and process chemistry.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting central nervous system (CNS) disorders, inflammation, or oncology.
  • Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and library synthesis in hit-to-lead optimization.
  • Process Development & Scale-up: Used in the development and optimization of robust, scalable synthetic routes for potential APIs under Good Manufacturing Practice (GMP) conditions.
  • Biochemical Probe Development: Employed in the creation of specialized chemical tools for investigating biological pathways and enzyme functions.
  • Contract Research & Manufacturing (CRAM): Supplied to organizations providing custom synthesis and development services for the global pharmaceutical industry.

Basic Information

Product Name 3-((1H-Imidazol-1-Yl)Methyl)-4,5,6,7-Tetrahydroisoxazolo[4,5-C]Pyridine
CAS No. 1422069-13-3
Molecular Formula C11H14N4O
Molecular Weight 218.26 g/mol
Synonyms 3-((1H-Imidazol-1-yl)methyl)-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine; 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine, 3-((1H-imidazol-1-yl)methyl)-; Tetrahydroisoxazolopyridine-imidazole derivative; Isoxazolopyridine-imidazole hybrid scaffold; Fused tricyclic imidazole intermediate
EINECS Contact for details

Quality Control

Our production of 3-((1H-Imidazol-1-Yl)Methyl)-4,5,6,7-Tetrahydroisoxazolo[4,5-C]Pyridine adheres to stringent quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and MS. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific client or regulatory requirements for research and development use.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). For long-term storage, consider under an inert atmosphere to maintain stability. Keep away from incompatible materials.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.